News & Updates
Filter by Specialty:
Hormone therapy prevents relapse in women with schizophrenia
The use of menopausal hormone therapy (MHT) can provide protection against psychosis relapse among women of menopausal age with schizophrenia or schizoaffective disorder (SSD), a study has shown.
Hormone therapy prevents relapse in women with schizophrenia
10 Oct 2024
Influenza-related complications common in kids with neuropsychiatric comorbidity
Neurologic and psychiatric complications associated with influenza occurs rarely in the paediatric population, but such incidence can be severe and may even lead to hospitalization, suggests a study.
Influenza-related complications common in kids with neuropsychiatric comorbidity
09 Oct 2024
4-year ischaemic stroke risk higher after patent foramen ovale closure
Patients with patent foramen ovale (PFO) closure have a greater risk of ischaemic stroke at 4 years than those in the general population, according to a study.
4-year ischaemic stroke risk higher after patent foramen ovale closure
08 Oct 2024
In utero exposure to flu spells increased risk of childhood seizures
Infants born to mothers who contracted influenza infection during pregnancy are at heightened risk of seizures, particularly febrile seizures, during childhood, according to a large study.
In utero exposure to flu spells increased risk of childhood seizures
03 Oct 2024
Can neurologic manifestations predict poor outcomes in young SARS-CoV-2, MIS-C patients?
A prospective cohort study has shown that in patients aged <18 years hospitalized for acute SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C), neurologic manifestations during the infection are common and may predispose them more to new neurocognitive or functional morbidity at discharge.
Can neurologic manifestations predict poor outcomes in young SARS-CoV-2, MIS-C patients?
03 Oct 2024
Novel AI tool for predicting cardio-cerebrovascular disease risk among Chinese
Researchers at the University of Hong Kong (HKU) have developed an innovative artificial intelligence (AI) assessment model that has the potential to fundamentally change the prevention and management of cardio-cerebrovascular (CCV) diseases specifically in the Chinese population.